This combination vial contains BPC-157 and TB-500 supplied together as a lyophilised powder in a sealed single-use vial, totalling 10mg, for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compounds: BPC-157 (Body Protection Compound-157) and TB-500 (thymosin beta-4 fragment). Format: lyophilised powder, combined vial. Total quantity: 10mg per vial. Purity: 98% minimum per compound, analytically verified. Appearance: white lyophilised powder. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - BPC-157 and TB-500 are frequently studied together in preclinical literature because they act through distinct mechanisms, which makes them useful in comparative and combination research designs. BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein and is examined for stability and growth factor pathway interaction. TB-500 corresponds to the actin-binding region of thymosin beta-4 and is examined for cytoskeletal dynamics and cell migration behaviour in in-vitro models. Supplying both in a single vial allows researchers to work with a fixed ratio across a study without separate reconstitution steps. Genesis Peptides supplies this combination in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Because this vial contains two compounds, note that reconstitution affects both simultaneously and the combined solution cannot be separated afterwards. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.